GlycoMimetics Inc (NASDAQ:GLYC)’s traded shares stood at 0.82 million during the last session, with the company’s beta value hitting 1.80. At the close of trading,
During the last session, GlycoMimetics Inc (NASDAQ:GLYC)’s traded shares were 0.63 million, with the beta value of the company hitting 1.79. At the end of
In the last trading session, 1.21 million shares of the GlycoMimetics Inc (NASDAQ:GLYC) were traded, and its beta was 1.78. Most recently the company’s share
GlycoMimetics Inc (NASDAQ:GLYC)’s traded shares stood at 0.59 million during the last session, with the company’s beta value hitting 1.78. At the close of trading,
In the last trading session, 1.26 million GlycoMimetics Inc (NASDAQ:GLYC) shares changed hands as the company’s beta touched 1.76. With the company’s per share price
GlycoMimetics Inc (NASDAQ:GLYC) has a beta value of 1.77 and has seen 1.85 million shares traded in the recent trading session. The company, currently valued
During the last session, GlycoMimetics Inc (NASDAQ:GLYC)’s traded shares were 1.01 million, with the beta value of the company hitting 1.79. At the end of
During the last session, GlycoMimetics Inc (NASDAQ:GLYC)’s traded shares were 3.46 million, with the beta value of the company hitting 1.81. At the end of
In the last trading session, 1.8 million shares of the GlycoMimetics Inc (NASDAQ:GLYC) were traded, and its beta was 1.82. Most recently the company’s share
In the last trading session, 2.22 million GlycoMimetics Inc (NASDAQ:GLYC) shares changed hands as the company’s beta touched 1.82. With the company’s per share price
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
